Targeting SARS‐CoV‐2 infection through CAR‐T‐like bispecific T cell engagers incorporating ACE2

por Dogan, Mikail, Kozhaya, Lina, Placek, Lindsey, Karabacak, Fatih, Yigit, Mesut, Unutmaz, Derya
Publicado 2022

731 FAILURE TO DEVELOP NEUTRALIZING ANTIBODIES FOLLOWING SARS-COV-2 INFECTION IN YOUNG PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING BIOLOGICS

por Dailey, Joelynn, Hyams, Jeffrey S., Hopkins, Dena, Grandonico, Kristen, Brimacombe, Michael, Lapin, Blaine, Schreiber, John, Kozhaya, Lina, Dogan, Mikail, Placek, Lindsey, Renzullo, Stephanie, Gunter, Courtney L., Salazar, Juan C., Unutmaz, Derya
Publicado 2021

Antibody Responses to SARS-CoV-2 After Infection or Vaccination in Children and Young Adults With Inflammatory Bowel Disease

por Dailey, Joelynn, Kozhaya, Lina, Dogan, Mikail, Hopkins, Dena, Lapin, Blaine, Herbst, Katherine, Brimacombe, Michael, Grandonico, Kristen, Karabacak, Fatih, Schreiber, John, Liang, Bruce Tsan-Liang, Salazar, Juan C, Unutmaz, Derya, Hyams, Jeffrey S
Publicado 2021

SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus

por Dogan, Mikail, Kozhaya, Lina, Placek, Lindsey, Gunter, Courtney, Yigit, Mesut, Hardy, Rachel, Plassmeyer, Matthew, Coatney, Paige, Lillard, Kimberleigh, Bukhari, Zaheer, Kleinberg, Michael, Hayes, Chelsea, Arditi, Moshe, Klapper, Ellen, Merin, Noah, Liang, Bruce Tsan-Tang, Gupta, Raavi, Alpan, Oral, Unutmaz, Derya
Publicado 2021